Haaartland

Login
Lilly diabetes executive becomes CMO at MannKind

inBrighter #Type1diabetes

Lilly diabetes executive becomes CMO at MannKind

Source: Fiercepharma

Bo

Bo

Your sidekick
Sweden

Bo
Your sidekick

  • 0

MannKind, which continues to try to convince the market of the value of its inhaled insulin, has enticed a top scientific executive away from Eli Lilly as it explores new areas for the fast-acting drug. The Westlake Village, California-based company Tuesday announced that David Kendall, M.D., has joined as MannKind's chief medical officer.

View original